Newsletter
Newsletter Support JNS

FDA clears new ReWalk product for stroke survivors

Israel-based ReWalk Robotics Ltd. announced that its ReStore product will have a starting price in the United States of $28,900, though leasing options will be available.

ReWalk Robotics Ltd.’s ReStore, an exoskeleton for stroke survivors. Credit: Screenshot.
ReWalk Robotics Ltd.’s ReStore, an exoskeleton for stroke survivors. Credit: Screenshot.

The Food and Drug Administration has cleared a new product geared to help stroke survivors walk again.

Israel-based ReWalk Robotics Ltd. announced on Tuesday that its ReStore product will have a starting price in the United States of $28,900, though leasing options will be available.

Last week, ReStore received the CE mark, allowing it to be sold in the European Union.

ReWalk Robotics Ltd. is known for its exoskeleton that enables paraplegics to walk again. It received FDA clearance in 2014.

Sharren Haskel, deputy Israeli minister of foreign affairs, told JNS that the Jewish state had offered Khanna full coordination, briefings, tours and security arrangements for his visit, “all of which he declined and didn’t even bother to reply to.”
More than 30 Israeli experts are aiding the earthquake-stricken country’s shift to long-term recovery.
Israeli forces eliminated Adham Ibrahim Sha’aban Nasman, who directed terrorists during the 2023 massacre, and two Islamic Jihad terrorists, including a Nova festival infiltrator.
Former BDS supporter Klaas Mokgomole told JNS that a firsthand visit to the Jewish state overturned years of anti-Israel indoctrination.
The strikes targeted command centers, missiles and air defenses to curb attacks on commercial shipping in the Strait of Hormuz, CENTCOM said.
“Due to heightened tensions in the Middle East, the security environment remains complex with the potential for unforeseen escalation.”